Pain Medicine, Interventional Pain Medicine · Tampa, FL
NPI
1649373697
Since 2006
Specialty
Pain Medicine, Interventional Pain Medicine
Code 208VP0014X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
13910 N Dale Mabry Hwy, Bldg 4, Ste 1
Tampa, FL, 33618
Phone (813) 963-2200
Groups this clinician bills Medicare through
Medicare paid, 2024
$69K
1,652 services
Medicare patients, 2024
99
Average age 69
Drug cost, 2024
$501K
13,206 prescriptions
Company payments, 2025
$717
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Vipul V Kabaria was code 99213 (office e&m - established), 493 times for 63 patients. In total Vipul V Kabaria billed 1,652 services in 27 codes, and Medicare paid $69K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-03-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 493 | 63 | $67.85 | $33K |
| 99214 Office E&M - Established | Office | 269 | 62 | $83.49 | $22K |
| 99203 Office E&M - New | Office | 17 | 17 | $77.58 | $1,319 |
| 99204 Office E&M - New | Office | 11 | 11 | $111.47 | $1,226 |
By year: 2022 $97K for 3,994 services; 2023 $71K for 1,544 services; 2024 $69K for 1,652 services.
Medicare prescription drug claims, 2024
In 2024, the drug Vipul V Kabaria prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 1,528 prescriptions and refills. In total Vipul V Kabaria wrote 13,206 Medicare prescriptions that cost $501K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 1,528 | 1,528 | 166 | $44K |
| Tizanidine Hcl Generic | 1,399 | 1,467 | 211 | $11K |
| Oxycodone Hcl Generic | 1,288 | 1,288 | 131 | $35K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 1,122 | 1,122 | 133 | $43K |
| Gabapentin Generic | 933 | 994 | 135 | $12K |
| Morphine Sulfate Er Morphine Sulfate | 892 | 892 | 91 | $32K |
| Diclofenac Sodium Generic | 680 | 694 | 191 | $18K |
| Pregabalin Generic | 519 | 547 | 80 | $13K |
| Tramadol Hcl Generic | 484 | 484 | 88 | $4,756 |
| Morphine Sulfate Generic | 455 | 455 | 50 | $14K |
| Baclofen Generic | 451 | 469 | 60 | $3,515 |
| Methadone Hcl Generic | 412 | 412 | 40 | $7,881 |
| Cyclobenzaprine Hcl Generic | 261 | 263 | 36 | $2,361 |
| Fentanyl Generic | 240 | 240 | 23 | $41K |
| Meloxicam Generic | 233 | 249 | 41 | $547 |
Brand drugs: - claims; generic drugs: 12,711 claims; opioid claims: 6,968.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Vipul V Kabaria $717 ($717 in general payments such as food, travel and fees) from 5 companies. The largest payer was Boston Scientific Corporation with $618.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.